Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12614000502639Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial of ropivacaine, ketorolac and epinephrine in postoperative pain (3 arms), sponsored by Nambour General Hospital. Primary endpoint: Highest postoperative pain score. Planned start Jun 2014; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12614000502639.